
Patient safety is a paramount concern throughout the life of a medicine. As a global pharmaceutical company, it is our ethical and regulatory responsibility to monitor the safety of the medicines we develop from their first introduction in the research laboratory, throughout clinical testing, and for as long as they are prescribed to patients anywhere in the world.
Pfizer is committed to developing innovative medicines and ensuring that healthcare professionals have access to the most current product safety information needed to make treatment decisions with their patients. In the sections below, you will learn more about:
Did you know that Pfizer in Canada invests more than $32 million annually through over 1,000 non-profit organizations and community groups?
Learn more about how we're helping
Did you know that it can take up to 10 years after a new product is discovered before it can be approved by Health Canada?
Find out more about clinical trials
You are now leaving the Pfizer.ca website.
Pfizer Canada accepts no responsibility for the content of linked sites.